512 related articles for article (PubMed ID: 31554928)
1. Targeting mRNA processing as an anticancer strategy.
Desterro J; Bak-Gordon P; Carmo-Fonseca M
Nat Rev Drug Discov; 2020 Feb; 19(2):112-129. PubMed ID: 31554928
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic Targeting of Alternative RNA Splicing in Gastrointestinal Malignancies and Other Cancers.
Sahin I; George A; Seyhan AA
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769221
[TBL] [Abstract][Full Text] [Related]
3. Altered RNA Processing in Cancer Pathogenesis and Therapy.
Obeng EA; Stewart C; Abdel-Wahab O
Cancer Discov; 2019 Nov; 9(11):1493-1510. PubMed ID: 31611195
[TBL] [Abstract][Full Text] [Related]
4. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
[TBL] [Abstract][Full Text] [Related]
5. Splicing in oncogenesis and tumor suppression.
Kaida D; Schneider-Poetsch T; Yoshida M
Cancer Sci; 2012 Sep; 103(9):1611-6. PubMed ID: 22691055
[TBL] [Abstract][Full Text] [Related]
6. Internal polyadenylation of the parvovirus B19 precursor mRNA is regulated by alternative splicing.
Guan W; Huang Q; Cheng F; Qiu J
J Biol Chem; 2011 Jul; 286(28):24793-805. PubMed ID: 21622561
[TBL] [Abstract][Full Text] [Related]
7. Chemical Modulation of Pre-mRNA Splicing in Mammalian Systems.
Boer RE; Torrey ZR; Schneekloth JS
ACS Chem Biol; 2020 Apr; 15(4):808-818. PubMed ID: 32191432
[TBL] [Abstract][Full Text] [Related]
8. RNA processing control in avian retroviruses.
McNally MT
Front Biosci; 2008 May; 13():3869-83. PubMed ID: 18508481
[TBL] [Abstract][Full Text] [Related]
9. Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis.
Gabriel M; Delforge Y; Deward A; Habraken Y; Hennuy B; Piette J; Klinck R; Chabot B; Colige A; Lambert C
BMC Cancer; 2015 Apr; 15():227. PubMed ID: 25884497
[TBL] [Abstract][Full Text] [Related]
10. Aberrant RNA splicing and therapeutic opportunities in cancers.
Yamauchi H; Nishimura K; Yoshimi A
Cancer Sci; 2022 Feb; 113(2):373-381. PubMed ID: 34812550
[TBL] [Abstract][Full Text] [Related]
11. Roles and mechanisms of alternative splicing in cancer - implications for care.
Bonnal SC; López-Oreja I; Valcárcel J
Nat Rev Clin Oncol; 2020 Aug; 17(8):457-474. PubMed ID: 32303702
[TBL] [Abstract][Full Text] [Related]
12. RNA Splicing in Cancer and Targeted Therapies.
Islam MR; Nagar P; Neetole ST; Wan L; Rahman MA
Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002963
[TBL] [Abstract][Full Text] [Related]
13. Elongation and maturation of c-myc RNA is inhibited by differentiation inducing agents in HL60 cells.
Eick D
Nucleic Acids Res; 1990 Mar; 18(5):1199-205. PubMed ID: 2320415
[TBL] [Abstract][Full Text] [Related]
14. The spliceosome is a therapeutic vulnerability in MYC-driven cancer.
Hsu TY; Simon LM; Neill NJ; Marcotte R; Sayad A; Bland CS; Echeverria GV; Sun T; Kurley SJ; Tyagi S; Karlin KL; Dominguez-Vidaña R; Hartman JD; Renwick A; Scorsone K; Bernardi RJ; Skinner SO; Jain A; Orellana M; Lagisetti C; Golding I; Jung SY; Neilson JR; Zhang XH; Cooper TA; Webb TR; Neel BG; Shaw CA; Westbrook TF
Nature; 2015 Sep; 525(7569):384-8. PubMed ID: 26331541
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
[TBL] [Abstract][Full Text] [Related]
16. In vitro polyadenylation is stimulated by the presence of an upstream intron.
Niwa M; Rose SD; Berget SM
Genes Dev; 1990 Sep; 4(9):1552-9. PubMed ID: 1701407
[TBL] [Abstract][Full Text] [Related]
17. [Disturbances of alternative splicing in cancer].
Wiszomirska H; Piekiełko-Witkowska A; Nauman A
Postepy Biochem; 2011; 57(3):257-65. PubMed ID: 22235651
[TBL] [Abstract][Full Text] [Related]
18. p53 is activated in response to disruption of the pre-mRNA splicing machinery.
Allende-Vega N; Dayal S; Agarwala U; Sparks A; Bourdon JC; Saville MK
Oncogene; 2013 Jan; 32(1):1-14. PubMed ID: 22349816
[TBL] [Abstract][Full Text] [Related]
19. Sde2 is an intron-specific pre-mRNA splicing regulator activated by ubiquitin-like processing.
Thakran P; Pandit PA; Datta S; Kolathur KK; Pleiss JA; Mishra SK
EMBO J; 2018 Jan; 37(1):89-101. PubMed ID: 28947618
[TBL] [Abstract][Full Text] [Related]
20. Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA.
Kaida D; Motoyoshi H; Tashiro E; Nojima T; Hagiwara M; Ishigami K; Watanabe H; Kitahara T; Yoshida T; Nakajima H; Tani T; Horinouchi S; Yoshida M
Nat Chem Biol; 2007 Sep; 3(9):576-83. PubMed ID: 17643111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
